StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic indefinite-Lived In-Process R&D (IPR&D) Balance ($M) ($M)

Quarterly figures from Medtronic's filings and investor materials

QuarterlyAnnual
Latest, Q1 FY27
265
Period ended Jul 31, 2026
Change on a year earlier
-8.6%
290 in Q1 FY26
History
19 quarters
Since Q4 FY18
Sources
18
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIndefinite-Lived In-Process R&D (IPR&D) Balance ($M) ($M)Year on yearSource
Q1 FY27Jul 31, 2026265-8.6%Medtronic Form 10-Q — FY2027Q1 (filed 2026-09-03) ↗
Q4 FY26Apr 30, 2026253-12.5%Medtronic Form 10-Q — FY2027Q1 (filed 2026-09-03) ↗
Q3 FY26Jan 31, 2026281-1.1%Medtronic Form 10-Q — FY2026Q3 (filed 2026-02-24) ↗
Q2 FY26Oct 31, 2025290+23.4%Medtronic Form 10-Q — FY2026Q2 (filed 2025-11-25) ↗
Q1 FY26Jul 31, 2025290-24.7%Medtronic Form 10-Q — FY2026Q1 (filed 2025-08-26) ↗
Q4 FY25Apr 30, 2025289-24.9%Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗
Q3 FY25Jan 31, 2025284+21.4%Medtronic Form 10-Q — FY2025Q3 (filed 2025-02-25) ↗
Q2 FY25Oct 31, 2024235-0.4%Medtronic Form 10-Q — FY2025Q2 (filed 2024-11-26) ↗
Q1 FY25Jul 31, 2024385+65.9%Medtronic Form 10-Q — FY2025Q1 (filed 2024-08-27) ↗
Q4 FY24Apr 30, 2024385+65.9%Medtronic Form 10-K — FY2025 (filed 2025-06-20) ↗
Q3 FY24Jan 31, 2024234–Medtronic Form 10-Q — FY2024Q3 (filed 2024-02-27) ↗
Q2 FY24Oct 31, 2023236–Medtronic Form 10-Q — FY2024Q2 (filed 2023-11-30) ↗
Q1 FY24Jul 31, 2023232–Medtronic Form 10-Q — FY2024Q1 (filed 2023-08-31) ↗
Q4 FY23Apr 30, 2023232-20.8%Medtronic Form 10-K — FY2024 (filed 2024-06-20) ↗
Q4 FY22Apr 30, 2022293-25.6%Medtronic Form 10-K — FY2023 (filed 2023-06-22) ↗
Q4 FY21Apr 30, 2021394-24.7%Medtronic Form 10-K — FY2022 (filed 2022-06-23) ↗

Cite this data

StockData. (2026). Medtronic Indefinite-Lived In-Process R&D (IPR&D) Balance ($M) ($M), quarterly Q4 FY18–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/intang-iprd

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.